In a significant step forward, the Ministry of Ayush has paved the way for strengthening the quality of Ayurvedic and other Indian Traditional Medicine products globally and also enhancing their export potential, especially to the USA Market. This has been achieved by signing of a Memorandum of Understanding (MoU) between the Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) and American Herbal Pharmacopoeia, USA on 13thSeptember, 2021.
The MoU was signed virtually and the Ministry of Ayush has entered this MOU with the specific purpose of strengthening, promotion, and development of standards in the field of Ayurveda and other Indian Traditional systems of medicine between the two countries on the basis of equality and mutual benefit.
This collaboration of efforts will go a long way in enhancing the export potential of the ASU&H (Ayurveda, Siddha, Unani and Homeopathy) drugs. Under this MOU, there will be the constitution of a Joint Committee to develop the action plan along with timelines for the development of Monographs and other activities for cooperation in the field of Traditional Medicine.
The Ministry feels that this MOU will develop the confidence of the global community about the safety of ASU&H drugs. One of the major outcomes of this partnership will be that both PCIM&H and AHP, USA would be working to identify various challenges faced by theherbal market of Ayurveda products/drugs in the USA. This will lead to adoption of Ayurveda standards developed out of this cooperation by the manufacturers of herbal drugs in the USA. This can be termed as a major move and will eventually foster the adoption of Ayurveda standards developed out of this cooperation for the market authorization of ASU&H products/drugs in the USA.
Development of Monographs of Ayurveda & other Indian Traditional Medicine products and herbal products, exchange of technical data for the development of Monographs with due acknowledgement between the parties, training and capacity building, exchange of Herbarium specimens and Botanical Reference Samples and phytochemical reference standards are also the part of MoU. There is an understanding in development of a Digital database on Ayurveda & other Indian Traditional Medicine products/drugs and herbal products and identifying further areas of co-operation for the promotion of quality standards of drugs/products used in Ayurveda & other Indian Traditional Medicine.
This MoU between India and USA is a timely step to add further momentum to the ongoing initiatives of the Ministry of Ayush to strengthen the quality of Ayurveda and other Indian Traditional Medicine products both inland and globally. Ayurveda and other AYUSH medicines have much to contribute in dealing with lifestyle disorders which are the major killers of this century.
Further, the role of ASU&H drugs in promoting the immunity of the body to fight against the prevalent infections is evidence based and worth praising. India enjoys the distinction of having the largest network of traditional health care systems which are widely accepted owing to its wide accessibility, affordability, safety and trust of people. It is the mandate of the Ministry of Ayush to work for promotion and propagation of these systems at international level for its global acceptance.
Through this MoU both the collaborators would strive to recognize the role of standards ensuring the quality and safety of Ayurveda and other Indian Traditional Medicine products. Will ensure an increase in awareness and understanding of the quality of traditional herbal medicines and their products.
Read More► Centre Enhances Financial Support to Open Ayush Colleges From Rs 9 Crore to Rs 70 Crore
आयुष मंत्रालय ने आयुर्वेदिक और अन्य भारतीय पारंपरिक दवाओं की गुणवत्ता बढ़ाने का रास्ता तैयार कर दिया है। इससे दुनिया में इन दवाओं की उपस्थिति बढ़ेगी और निर्यात क्षमता में भी वृद्धि होगी। इसमें अमेरिका के बाजार का विशेष स्थान है। भारतीय चिकित्सा एवं होम्योपैथी भेषजसंहिता आयोग (पीसीआईएम-एंड-एच) ने अमेरिकन हर्बल फॉर्माकोपिया (एएचपी) के साथ 13 सितंबर, 2021 को एक समझौता-ज्ञापन पर हस्ताक्षर करके यह महत्त्वपूर्ण काम अंजाम दिया है।
इस समझौता-ज्ञापन पर वर्चुअल माध्यम से हस्ताक्षर किये गये। समझौता करने के सम्बंध में आयुष मंत्रालय का उद्देश्य है कि दोनों देशों के बीच बराबरी तथा आपसी लाभ के आधार पर आयुर्वेद और अन्य भारतीय पारंपरिक औषधि प्रणालियों को प्रोत्साहित किया जाये और उनके मानकीकरण का विकास किया जाये।
इस सहयोग से आयुर्वेद, सिद्ध, यूनानी और होम्योपैथी दवाओं की निर्यात क्षमता को बढ़ाने के दूरगामी प्रयास होंगे। समझौते के तहत एक संयुक्त समिति का गठन किया जायेगा, ताकि पारंपरिक औषधि के क्षेत्र में सहयोग के हवाले से मोनोग्राफ के विकास तथा अन्य गतिविधियों के लिये समय-सीमा के साथ एक कार्य योजना भी विकसित की जाये।
आयुष मंत्रालय को विश्वास है कि इस समझौते से आयुर्वेद, सिद्ध, यूनानी और होम्योपैथी दवाओं के बारे में विश्व समुदाय में भरोसा पैदा होगा। इस साझेदारी का एक प्रमुख नतीजा यह होगा कि पीसीआईएम-एंड-एच और एएचपी, अमेरिका में आयुर्वेद उत्पादों/दवाओं के बाजार के सामने आने वाली विभिन्न चुनौतियों की मिलकर पहचान करेंगे। इस कदम से सहयोग के तहत विकसित होने वाले आयुर्वेद मानकों को अमेरिका के हर्बल दवाओं के निर्माता अपना लेंगे। इसे एक बड़ा कदम कहा जा सकता है और फलस्वरूप सहयोग के तहत विकसित आयुर्वेद मानकों को अपनाये जाने से अमेरिकी बाजार में आयुर्वेद, सिद्ध, यूनानी और होम्योपैथी दवाओं को बेचने का रास्ता खुल जायेगा।
आयुर्वेद और अन्य भारतीय पारंपरिक औषधियों और जड़ी-बूटियों से बने उत्पादों के लिये मोनोग्राफ का विकास, पक्षों के बीच मोनोग्राफ के विकास के लिये तकनीकी आंकड़ों का आदान-प्रदान, प्रशिक्षण और क्षमता निर्माण, जड़ी-बूटियों के नमूने, वनस्पतियों के नमूने तथा पौधों के रासायनिक मानकों को भी समझौते का अंग बनाया गया है। दोनों पक्षों के बीच यह समझ भी बनी है कि आयुर्वेद और अन्य भारतीय पारंपरिक दवा उत्पादों तथा जड़ी-बूटियों के उत्पादों के लिये एक डिजिटल डेटाबेस बनाया जाये। इसके तहत आयुर्वेद और अन्य भारतीय पारंपरिक दवाओं के इस्तेमाल के बारे में गुणवत्ता मानकों को प्रोत्साहित करने के लिये सहयोग के अन्य उपायों की पहचान की जायेगी।
भारत और अमेरिका के बीच यह समझौता ऐसे समय में हुआ है, जब आयुष मंत्रालय भारत और विदेश में आयुर्वेद तथा अन्य भारतीय पारंपरिक औषधीय उत्पादों की गुणवत्ता बेहतर बनाने के लिये कई कदम उठा रहा है। आयुर्वेद और अन्य आयुष दवाओं ने गलत जीवन-शैली से पैदा होने वाली बीमारियों से निपटने में बहुत योगदान किया है। इन बीमारियों से इस सदी में तमाम लोग मृत्यु को प्राप्त हुये हैं।
इसके अलावा, संक्रमण के खिलाफ लड़ने को शरीर की रोग विरोधी क्षमता को बढ़ाने में भी आयुर्वेद, सिद्ध, यूनानी और होम्योपैथी की अहम भूमिका है, जिसके प्रमाण सबके सामने हैं। यह अत्यंत प्रसंशनीय है। भारत को पारंपरिक स्वास्थ्य सुविधा प्रणाली का वरदान मिला है। यह प्रणालियां बड़े पैमाने पर मान्य हैं, क्योंकि ये आसानी से उपलब्ध हैं, सस्ती, सुरक्षित हैं और लोगों को उन पर भरोसा है। यह आयुष मंत्रालय के अधिकार-क्षेत्र में है कि वह इन औषधियों को दुनिया भर में मान्य करने के लिये वह अंतर्राष्ट्रीय स्तर पर इन प्रणालियों का प्रचार-प्रसार करे।
इस समझौता-ज्ञापन से दोनों पक्ष आयुर्वेद और अन्य भारतीय पारंपरिक औषधीय उत्पादों की गुणवत्ता तथा सुरक्षा सुनिश्चित करने के लिये मानकों की भूमिका को मान्यता प्रदान करेंगे। इससे पारंपरिक/हर्बल दवाओं और उनके उत्पादों की गुणवत्ता के प्रति समझ तथा जागरूकता बढ़ेगी।
यह भी पढ़े► केंद्र पूर्वोत्तर में नए आयुष कॉलेज खोलने में मदद को तैयार: सर्बानंद सोनोवाल
Chandigarh, Aug 20 (IANS) Haryana Chief Minister Manohar Lal Khattar on Friday said the state has been giving a benefit of Rs 2 lakh to poor families under an insurance scheme, who have lost members during the Covid-19 pandemic.The Chief Minister informed the state assembly about this during the Question Hour on the first day of the monsoon session that commenced here.Adequate arrangements have been made for ensuring uninterrupted oxygen supply during the pandemic, he said."Initially, Haryana got a quota of 150 metric tonnes (MT) oxygen from the Centre, which was later increased to 285 MT, although the state had demanded 350 MT," he said.The Chief Minister said to ensure uninterrupted oxygen supply, adequate arrangements were made. No discrimination of any kind was done in the supply of oxygen. During the second wave, the daily oxygen supply and requirement were calculated thoroughly, he said."Not only this, concentrators were also brought to ensure adequate supply of oxygen. Many social organizations also contributed to this," said Khattar."Currently, there are 670 active COVID-19 cases in Haryana. A third wave is expected. Even today many people are struggling with post-Covid complications. Pandemic is not in anyone's control. We have done our duty in times of crisis," added Khattar.He blamed the opposition for criticizing the government on every issue.Replying to another question, Cooperation Minister Banwari Lal, on behalf of Health Minister Anil Vij, said 26 healthcare personnel, comprising nine doctors and eight paramedical staff, lost their lives while performing Covid-19 duty. They were covered under a life insurance scheme.He said the state saw 9,635 Covid deaths and district-level death audit committees were constituted to evaluate the cause of death so that corrective measures were taken accordingly.--IANSvg/bg
Chandigarh, Aug 20 (IANS) Haryana Health Minister Anil Vij, who earlier contracted coronavirus, was put on oxygen support on Friday after his oxygen levels dipped alarmingly, a doctor said.Dhruv Chaudhary, Head of Pulmonary Medicine Department of the Post-Graduate Institute of Medical Sciences, Rohtak, who is monitoring Vij's condition, told the media that Vij was put on oxygen support at his residence in Ambala city, some 50 km from here.He said the minister's oxygen level dipped below 80 in the morning. By the evening the oxygen saturation reached 89, but it was still low."We are monitoring his condition and if required, he will be hospitalised," Chaudhary added.On November 20, Vij was given a shot of Bharat Biotech's 'Covaxin' for which he had volunteered.Later, the Hyderabad-based Bharat Biotech had said the efficacy of its Covid-19 vaccine could be determined only 14 days after a second dose."Covaxin has been designed to be efficacious. Covaxin clinical trials are based on a two-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days post the second dose," the company had said in a statement.--IANSvg/vd
Gurugram, Aug 12 (IANS) In a unique initiative, the health department of Nuh district in Haryana, along with M3M Foundation, on Thursday launched the 'Jan Swasthya Chetna Yatra' -- an awareness-cum-vaccination campaign.The campaign, to be held between August 12-31, focuses on ramping up vaccination and shedding vaccine-related hesitancy among communities in 64 villages. It also aims to vaccinate more than 4,000 residents and reach out to over 10,000 people through the awareness drive to prepare for a possible third wave of coronavirus.Dr. Surender Yadav, Chief Medical Officer, Nuh, said: "Earlier, the vaccination in this area had been the lowest but the speed of daily vaccination has increased significantly in the last two months. "This initiative will give a much-needed boost to it. Our health workers were not able to reach at the village level to answer everyone's questions, but the plan of this campaign is such that people can now easily ask their questions and doubts related to vaccines.Yadav hoped that the campaign will create awareness among the people and also accelerate the vaccination process. "Since this area is completely rural, this campaign will gain momentum when people will get to know about it," he said.During the inaugural event, Dr. Payal Kanodia, Trustee, M3M Foundation, said: "It is extremely crucial to safeguard the last person standing in the line to win the war against the pandemic. This campaign will largely benefit the underprivileged sections of the society to get vaccinated easily and as early as possible".Officials said 600 doses were provided on the first day of the campaign and vaccination is going on smoothly. Over 300 people had already registered themselves a day before the campaign.--IANSstr/pgh
Gurugram, Aug 11 (IANS) Gurugram district has achieved the first position in Haryana in administering the first dose of Covid-19 vaccine to the 18 to 44 year age group people.District Civil Surgeon Dr Virender Yadav said it was a great achievement of the health department."It was a joint effort of the health department as well as people of the district who were aware of the Covid-19 vaccine pros and cons which helps Gurugram to bag first position across the state. The department will continue to plan such vaccination drives of Covid-19 jab to cover maximum people in Gurugram," Yadav told IANS.Dr MP Singh, the nodal officer and deputy civil surgeon of the vaccination campaign, said that Gurugram stood first among 22 districts of the state in giving the first dose to its residents in the age group of 18 to 44 years."In Gurugram, 91 percent people have been vaccinated so far, while Dadri district with 65 percent and Panchkula district with 61 percent are in second and third place respectively. Gurugram is at third place in the second dose vaccination for the same age group," Singh said.Singh said that Gurugram is leading the entire state in the vaccination campaign due to the tireless efforts of its health workers."Gurugram is second in providing the first anti-corona vaccine to 54 percent of its citizens in the age group of 45 to 60 years. Ambala is in the first place by vaccinating 81 percent of people and Rewari is in third place with 40 percent," he said.--IANSstr/bg